Evidence map›Paper›PMID 23921069›Full record

ArticleBMJ open2013

Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial.

Noppawan Charususin, Rik Gosselink, Marc Decramer, Alison McConnell, Didier Saey, Francois Maltais, Eric Derom, Stefanie Vermeersch, Hanneke van Helvoort, Yvonne Heijdra and 4 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01397396 phase3completednot on this map

Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease - a Randomized Controlled Trial

TypeinterventionalSponsorKU LeuvenRan2012 to 2016Enrolled208ConditionsCOPD, Inspiratory Muscle WeaknessArmsInspiratory Muscle Training
NCT02963844 nacompletednot on this mapstarted 2016, after this paper: background citation

The Inspiratory Muscle Training Improves the Severity of Obstructive Sleep Apnea and Sleep Quality?

TypeinterventionalSponsorUniversidade Federal de PernambucoRan2016 to 2020Enrolled16ConditionsSleep Apnea, ObstructiveArmsInspiratory Muscle Training, Inspiratory Muscle Training Sham
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Improving respiratory muscle strength and health status in burn patients: a randomized controlled trial.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 6 countries.

Noppawan CharususinDepartment of Rehabilitation Sciences, University of Leuven, Leuven, Belgium.
Rik Gosselink
Marc Decramer
Alison McConnell
Didier Saey
Francois Maltais
Eric Derom
Stefanie Vermeersch
Hanneke van Helvoort
Yvonne Heijdra
Mariska Klaassen
Rainer Glöckl
Klaus Kenn
Daniel Langer
Radboud University Nijmegen · NLUniversitair Ziekenhuis Leuven · BEGhent University Hospital · BEInstitut universitaire de cardiologie et de pneumologie de Québec · CASchön Klinik Berchtesgadener Land · DEBrunel University of London · GBThammasat University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInspiratory muscle training (IMT) has been applied during pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD). However, it remains unclear if the addition of IMT to a general exercise training programme leads to additional clinically relevant improvements in patients with COPD. In this study, we will investigate whether the addition of IMT to a general exercise training programme improves 6 min walking distance, health-related quality of life, daily physical activity and inspiratory muscle function in patients with COPD with inspiratory muscle weakness. METHODS AND ANALYSIS: Patients with COPD (n=170) with inspiratory muscle weakness (Pi,max <60 cm H2O or <50%pred) will be recruited to a multicentre randomised placebo controlled trial of IMT and allocated into one of the two groups. Patients in both groups will follow a 3 month general exercise training programme, in combination with home-based IMT. IMT will be performed with a recently developed device (POWERbreathe KH1). This device applies an inspiratory load that is provided by an electronically controlled valve (variable flow resistive load). The intervention group (n=85) will undertake an IMT programme at a high intensity (≥50% of their Pi,max), whereas the placebo group (n=85) will undertake IMT at a low training intensity (≤10% of Pi,max). Total daily IMT time for both groups will be 21 min (6 cycles of 30 breaths). Improvement in the 6 min walking distance will be the primary outcome. Inspiratory muscle function, health-related quality of life and daily physical activity will be assessed as secondary outcomes. ETHICS AND DISSEMINATION: Ethics approval has been obtained from relevant centre committees and the study has been registered in a publicly accessible clinical trial database. The results will be easily interpretable and should immediately be communicated to healthcare providers, patients and the general public.

resultsThis can be incorporated into evidence-based treatment recommendations for clinical practice. CLINICALTRIALSGOV: NCT01397396.

Identifiers

PMID23921069
PMCPMC3740252
OpenAlexW2112625969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.